The Cooper Companies, Inc. Profile Avatar - Palmy Investing

The Cooper Companies, Inc.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses…

Medical - Instruments & Supplies
US, San Ramon [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
2014 5.6100 6.920 1,717 1,702 269 263 340 433 306 300 683 677
2015 4.2000 1.886 1,797 1,816 203 198 285 414 236 230 712 700
2016 5.6500 2.106 1,966 1,953 273 259 382 489 324 306 722 678
2017 7.6300 2.428 2,139 2,136 372 356 495 588 429 410 799 765
2018 2.8500 2.903 2,532 2,526 139 158 585 681 427 398 973 959
2019 2.3600 3.081 2,653 2,645 466 440 672 779 527 516 996 935
2020 1.2100 2.394 2,430 2,425 238 216 440 556 311 288 992 969
2021 14.9600 3.332 2,922 2,912 2,944 2,621 660 771 505 473 1,211 1,144
2022 1.9600 13.920 3,308 3,305 385 1,004 712 903 507 517 1,342 1,372
2023 1.4900 3.201 3,593 3,590 294 294 704 993 533 569 1,501 1,509
2024 - 3.660 - 3,905 - 729 - 837 - 382 - 1,579
2025 - 4.082 - 4,204 - 806 - 901 - 412 - 1,700
2026 - 2.F12X/td> - 2.F12X/td> - 2.F12X/td> - 2.F121/td> - 2.F121 - 2.F121
2027 - 1.F13X/td> - 1.F13X/td> - 1.F13X/td> - 1.F131/td> - 1.F131 - 1.F131
2028 - 0.F14X/td> - 0.F14X/td> - 0.F14X/td> - 0.F141/td> - 0.F141 - 0.F141
End of COO's Analysis
CIK: 711404 CUSIP: 216648402 ISIN: US2166485019 LEI: - UEI: -
Secondary Listings
COO has no secondary listings inside our databases.